Growth Metrics

Intelligent Bio Solutions (INBS) Equity Ratio (2020 - 2025)

Intelligent Bio Solutions has reported Equity Ratio over the past 5 years, most recently at 0.59 for Q2 2024.

  • For Q2 2024, Equity Ratio rose 66.79% year-over-year to 0.59; the TTM value through Jun 2024 reached 0.59, up 66.79%, while the annual FY2024 figure was 0.59, 66.79% up from the prior year.
  • Equity Ratio for Q2 2024 was 0.59 at Intelligent Bio Solutions, down from 0.65 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.94 in Q4 2020 and troughed at 2.11 in Q2 2020.
  • A 5-year average of 0.42 and a median of 0.58 in 2022 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: skyrocketed 132.59% in 2021 and later tumbled 72.21% in 2023.
  • Year by year, Equity Ratio stood at 0.94 in 2020, then fell by 29.91% to 0.66 in 2021, then decreased by 13.75% to 0.57 in 2022, then tumbled by 37.16% to 0.36 in 2023, then skyrocketed by 66.2% to 0.59 in 2024.
  • Business Quant data shows Equity Ratio for INBS at 0.59 in Q2 2024, 0.65 in Q1 2024, and 0.36 in Q4 2023.